The firm acquired intellectual property from Mammoth Biosciences that will reduce the speed and cost of its in-development point-of-care solution.

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

Epicrispr Biotechnologies CEO Amber Salzman, Ph.D. offers up four imperatives for industry leaders working to develop ...

Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection ...

Cathie Wood is known for seizing opportunities. The founder of Ark Invest doesn't worry when one of the stocks she's invested ...

More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, ...

On Wednesday morning, Poland shot down several Russian drones that entered its airspace—a first since Moscow’s invasion of ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene editing tools such as CRISPR ...

6."The ozone layer is actually healing faster than expected. Scientists think it could be fully restored in our lifetime." ...

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. Prime Medicine, Inc. ( NASDAQ: PRME) Morgan Stanley 23rd Annual Global Healthcare ...

As China threatens to overtake U.S. leadership in science and technology, America has responded by sabotaging its own engines ...